GBM
Glioblastoma multiforme, the most aggressive primary brain cancer, characterized by hundreds of mutations and poor survival
As defined in Novocure: Using Physics to Fight Cancer
Where it comes up · 1
Most important claims · 3 of 3Search all claims for “GBM” →
- In the pivotal glioblastoma trial, the control group receiving radiation plus temozolomide had about 5 percent five-year survival, while adding Tumor Treating Fields raised five-year survival to about 13 percent, with survival curves separating at every point.Novocure: Using Physics to Fight Cancer
- Glioblastoma has seen over 35 phase three drug trials fail, because the blood-brain barrier limits drug delivery, surgery and radiation are constrained by the brain's location, and the tumor's many mutations make it resistant.Novocure: Using Physics to Fight Cancer
- Glioblastoma's median age at diagnosis is in the late 50s, though it affects both younger and older patients, so it is not primarily a geriatric cancer.Novocure: Using Physics to Fight Cancer